XNK Therapeutics has announced the appointment of Peter Hovstadius as Chief Medical Officer (CMO), effective immediately.
Hovstadius will be a member of the company’s management team. Johan Aschan who retires from his position as CMO will continue as the company’s Senior Medical Advisor.